Cargando…
CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin‐C vs surgical management in low‐risk non‐muscle‐invasive bladder cancer
OBJECTIVES: To evaluate the activity of intravesical mitomycin‐C (MMC) to ablate recurrent low‐risk non‐muscle‐invasive bladder cancer (NMIBC) and assess whether it may enable patients to avoid surgical intervention for treatment of recurrence. PATIENTS AND METHODS: CALIBER is a phase II feasibility...
Autores principales: | Mostafid, A. Hugh, Porta, Nuria, Cresswell, Joanne, Griffiths, Thomas R.L., Kelly, John D., Penegar, Steven R., Davenport, Kim, McGrath, John S., Campain, Nicholas, Cooke, Peter, Masood, Shikohe, Knowles, Margaret A., Feber, Andrew, Knight, Allen, Catto, James W.F., Lewis, Rebecca, Hall, Emma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318672/ https://www.ncbi.nlm.nih.gov/pubmed/32124514 http://dx.doi.org/10.1111/bju.15038 |
Ejemplares similares
-
Correction to: Meeting abstracts from the 4th International Clinical Trials Methodology Conference (ICTMC) and the 38th Annual Meeting of the Society for Clinical Trials
por: Penegar, Steven, et al.
Publicado: (2018) -
Alcohol-free EUS-guided chemoablation of multiple pancreatic insulinomas
por: Gaballa, Daniel, et al.
Publicado: (2019) -
Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer
por: Elliott, Daisy, et al.
Publicado: (2018) -
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression
por: Bryant, Richard J., et al.
Publicado: (2020) -
Transcatheter real-time MRI guided myocardial chemoablation using acetic acid
por: Rogers, Toby, et al.
Publicado: (2016)